Search results
William Ho is the Co-Founder, President, CEO and Director of IN8bio, a biotechnology company. He has over 20 years of experience in the industry, working as an investor, analyst and executive at various firms.
Nov 20, 2023 · William Ho is a biotech entrepreneur and investor who co-founded IN8bio, a company developing gamma-delta T-Cells as cellular therapies for cancer. He explains how gamma-delta T-Cells can kill tumor cells without causing toxicity and how they can be used for both solid and liquid tumors.
- Mike Hollan
William Ho is a company Co-Founder, and has served as the President, Chief Executive Officer and Director of IN8bio since its inception. Mr. Ho has worked in the biotechnology industry for almost 20 years.
- Director, President, CEO & Co-Founder
- In8bio, In8bio
William Ho: I’ve been in the biotech industry for over 22 years, and much of that was spent on the Wall Street side (investor banking, equity research, and as an investor). I co-founded the company together in 2016, and today we’re one of the leading companies developing gamma-delta T-Cells in oncology as a cellular therapy.
Feb 26, 2024 · William Ho is the founder and CEO of IN8bio, a biotechnology company focused on immunotherapy. He will speak at the BIO CEO & Investor Conference in New York in February 2025.
William Ho is the CEO and co-founder of IN8bio, a biotechnology company. He has experience in healthcare investing, research, and banking, and was a former analyst at AlephPoint Capital and New Leaf Venture Partners.
William Ho is the CEO and co-founder of IN8bio, a biotech company developing gamma-delta T cell therapies for cancer. He has over 4K followers and 500+ connections on LinkedIn, where he shares articles, news and events related to his work and industry.
